BillDoyle_2011P 1 BillDoyle_2011P 13.27 22.28 <NA> <unk> in our society 's life is touched by cancer if not personally then through a loved one a family member <unk> colleague friend <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 22.36 25.29 <NA> and once our lives are touched by cancer
BillDoyle_2011P 1 BillDoyle_2011P 25.82 29.74 <NA> <unk> we quickly learn that there are basically
BillDoyle_2011P 1 BillDoyle_2011P 29.53 38.67 <NA> three weapons or three tools that are available to fight the disease <unk> surgery radiation and chemotherapy 
BillDoyle_2011P 1 BillDoyle_2011P 38.42 42.45 <NA> and once we get involved in
BillDoyle_2011P 1 BillDoyle_2011P 42.29 47.56 <NA> the therapeutic decisions again either personally or or with our
BillDoyle_2011P 1 BillDoyle_2011P 47.56 52.26 <NA> loved ones and family members <unk> we also very quickly learn
BillDoyle_2011P 1 BillDoyle_2011P 51.77 53.44 <NA> the benefits the
BillDoyle_2011P 1 BillDoyle_2011P 54.54 61.48 <NA> <unk> limitations of of these tools i 'm very thankful to jay and to mark and the tedmed team
BillDoyle_2011P 1 BillDoyle_2011P 61.11 62.98 <NA> for inviting me today
BillDoyle_2011P 1 BillDoyle_2011P 62.81 69.34 <NA> to describe a fourth tool a new tool that we call tumor treating fields <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 69.03 78.02 <NA> tumor treating fields were invented by dr yoram palti <unk> professor emeritus at the technion in israel <unk> and they use
BillDoyle_2011P 1 BillDoyle_2011P 79.72 83.45 <NA> <unk> electric fields to fight cancer 
BillDoyle_2011P 1 BillDoyle_2011P 83.11 92.27 <NA> to understand how tumor treating fields work <unk> we first need to understand what are electric fields let me first
BillDoyle_2011P 1 BillDoyle_2011P 92.59 94.73 <NA> address a few
BillDoyle_2011P 1 BillDoyle_2011P 94.54 101.42 <NA> popular misconceptions first of all electric fields are not an electric current that is
BillDoyle_2011P 1 BillDoyle_2011P 101.17 104.97 <NA> coursing through the tissue electric fields
BillDoyle_2011P 1 BillDoyle_2011P 105.17 112.87 <NA> are not ionizing radiation like x rays or proton beams that bombard tissue to disrupt dna <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 112.87 117.72 <NA> and electric fields are not magnetism <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 117.65 124.83 <NA> what electric fields are are a field of forces and these forces
BillDoyle_2011P 1 BillDoyle_2011P 124.46 129.49 <NA> act on attract <unk> bodies that have an electrical charge
BillDoyle_2011P 1 BillDoyle_2011P 130.02 134.5 <NA> <unk> the best way to visualize an electric field is to think of gravity <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 134.1 142.06 <NA> gravity is also a field of forces that act on masses we can all picture astronauts in space 
BillDoyle_2011P 1 BillDoyle_2011P 142.06 146.74 <NA> they float freely in three dimensions without any forces acting on them <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 146.25 148.25 <NA> but as that
BillDoyle_2011P 1 BillDoyle_2011P 148.01 150.08 <NA> space shuttle returns
BillDoyle_2011P 1 BillDoyle_2011P 151.21 163.52 <NA> <unk> and as the astronauts enter the earth 's gravitational field they begin to see the effects of gravity they begin to be attracted towards earth <unk> and as they land they 're fully aligned in the gravitational field we 're
BillDoyle_2011P 1 BillDoyle_2011P 163.03 168.24 <NA> of course all stuck in the earth 's gravitational field right now that 's why you 're all
BillDoyle_2011P 1 BillDoyle_2011P 168 174.96 <NA> in your chairs <unk> and that 's why we have to use our muscle energy to stand up to walk around and to lift
BillDoyle_2011P 1 BillDoyle_2011P 176.63 183.78 <NA> <unk> in cancer cells rapidly divide and lead to uncontrolled tumor growth 
BillDoyle_2011P 1 BillDoyle_2011P 183.62 191.34 <NA> we can think of a cell from an electrical perspective as if it 's a mini space station <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 191.06 198.12 <NA> and in that space station we have the genetic material the chromosomes within a nucleus <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 198.12 202.87 <NA> and out in the cytoplasmic soup we have special proteins
BillDoyle_2011P 1 BillDoyle_2011P 202.7 204.88 <NA> that are required for cell division
BillDoyle_2011P 1 BillDoyle_2011P 205.02 208.07 <NA> <unk> that float freely in this soup in three dimensions 
BillDoyle_2011P 1 BillDoyle_2011P 208.07 215.2 <NA> importantly those special proteins are among the most highly charged objects in our body <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 215.55 218.09 <NA> as cell division begins
BillDoyle_2011P 1 BillDoyle_2011P 217.9 225.2 <NA> the nucleus disintegrates <unk> the chromosomes line up in the middle of the cell and those special
BillDoyle_2011P 1 BillDoyle_2011P 230.68 233.94 <NA> <unk> whereby they attach and they literally click into place
BillDoyle_2011P 1 BillDoyle_2011P 235.08 238.71 <NA> to form chains these chains
BillDoyle_2011P 1 BillDoyle_2011P 238.5 248.6 <NA> then progress and attach to the genetic material and pull the genetic material from one cell into two cells 
BillDoyle_2011P 1 BillDoyle_2011P 248.6 254.97 <NA> and this is exactly how one cancer cell becomes two cancer cells two cancer cells become four cancer cells and we
BillDoyle_2011P 1 BillDoyle_2011P 254.93 261.66 <NA> <unk> have ultimately uncontrolled tumor growth tumor treating fields
BillDoyle_2011P 1 BillDoyle_2011P 261.86 270.93 <NA> use externally placed transducers attached to a field generator to create
BillDoyle_2011P 1 BillDoyle_2011P 270.53 274.84 <NA> an artificial electric field on that space station <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 276.27 285.76 <NA> <unk> and when that cellular space station is within the electric field it acts on those highly charged proteins
BillDoyle_2011P 1 BillDoyle_2011P 285.27 287.17 <NA> and aligns them 
BillDoyle_2011P 1 BillDoyle_2011P 286.89 297.02 <NA> and it prevents them from forming those chains <unk> those mitotic spindles that are necessary to pull the genetic material into the daughter cells 
BillDoyle_2011P 1 BillDoyle_2011P 297.02 304.45 <NA> what we see is that the cells will attempt to divide for several hours and they will either
BillDoyle_2011P 1 BillDoyle_2011P 304.87 314.15 <NA> <unk> into this so called cellular suicide programmed cell death or they will form unhealthy daughter cells and enter into
BillDoyle_2011P 1 BillDoyle_2011P 314.11 322.4 <NA> apoptosis once they have divided <unk> and we can observe this what i 'm going to show you next are two
BillDoyle_2011P 1 BillDoyle_2011P 322.3 324.98 <NA> in vitro experiments this is
BillDoyle_2011P 1 BillDoyle_2011P 325.67 337.08 <NA> <unk> identical cultures of cervical cancer cells and we 've stained these cultures with a green florescent dye so that we can look at these proteins that form these chains <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 337.08 338.94 <NA> the first clip
BillDoyle_2011P 1 BillDoyle_2011P 338.66 344.7 <NA> shows a normal cell division without the
BillDoyle_2011P 1 BillDoyle_2011P 344.33 349.78 <NA> tumor treating fields <unk> what we see are first of all a very active
BillDoyle_2011P 1 BillDoyle_2011P 350.49 356.95 <NA> <unk> a lot of divisions <unk> and then very clear nuclei once the cells have separated and we can see them dividing
BillDoyle_2011P 1 BillDoyle_2011P 356.58 358.21 <NA> throughout 
BillDoyle_2011P 1 BillDoyle_2011P 357.9 364.99 <NA> when we apply the fields again in the identical time scale to the identical culture you 're going to see something different 
BillDoyle_2011P 1 BillDoyle_2011P 364.99 370.81 <NA> the cells round up for division but they 're very static in that position we
BillDoyle_2011P 1 BillDoyle_2011P 370.59 374.93 <NA> 'll see two cells in the upper part of the
BillDoyle_2011P 1 BillDoyle_2011P 377.68 379.26 <NA> <unk> attempting to divide 
BillDoyle_2011P 1 BillDoyle_2011P 379.05 389.41 <NA> the one within the circle manages but see how much of the protein is still throughout the nucleus <unk> even in the dividing cell the one up there can 't divide at all 
BillDoyle_2011P 1 BillDoyle_2011P 389.42 391.65 <NA> and then this bubbling <unk> this
BillDoyle_2011P 1 BillDoyle_2011P 391.47 400.07 <NA> membrane bubbling is the hallmark of apoptosis in this cell formation of healthy
BillDoyle_2011P 1 BillDoyle_2011P 399.67 404.94 <NA> mitotic spindles is necessary for division in
BillDoyle_2011P 1 BillDoyle_2011P 404.9 410.55 <NA> <unk> all cell types we 've applied tumor treating fields to over twenty different
BillDoyle_2011P 1 BillDoyle_2011P 410.06 417.27 <NA> cancers in the lab <unk> and we see this effect in all of them now
BillDoyle_2011P 1 BillDoyle_2011P 416.96 425.11 <NA> importantly <unk> these tumor treating fields have no effect on normal undividing cells ten
BillDoyle_2011P 1 BillDoyle_2011P 426.48 430.22 <NA> <unk> palti founded a company called novocure to develop
BillDoyle_2011P 1 BillDoyle_2011P 429.98 437 <NA> his discovery into a practical therapy for patients in that time novocure 's developed
BillDoyle_2011P 1 BillDoyle_2011P 436.76 444.61 <NA> two systems one system for cancers in the head and another system for cancers in the trunk of the body <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 444.54 449.78 <NA> the first cancer that we have focused on is the deadly brain cancer
BillDoyle_2011P 1 BillDoyle_2011P 451.87 454.58 <NA> <unk> affects about ten thousand people
BillDoyle_2011P 1 BillDoyle_2011P 454.12 456.68 <NA> in the u s each year
BillDoyle_2011P 1 BillDoyle_2011P 456.46 462.62 <NA> <unk> it 's a death sentence <unk> the expected five year survival is less than five percent 
BillDoyle_2011P 1 BillDoyle_2011P 462.42 469.09 <NA> and the typical patient with optimal therapy survives just a little over a year <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 469.09 477.21 <NA> and only about seven months from the time that the cancer is first treated and then comes back and starts growing again
BillDoyle_2011P 1 BillDoyle_2011P 479.72 488.67 <NA> <unk> conducted its first phase three randomized trial in patients with recurrent gbm <unk> so these are patients who had received
BillDoyle_2011P 1 BillDoyle_2011P 489.26 491.22 <NA> surgery <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 490.79 500.23 <NA> high dose radiation to the head and first line chemotherapy and that had failed and their tumors had grown back <unk> we divided the patients
BillDoyle_2011P 1 BillDoyle_2011P 504.84 513.79 <NA> <unk> which is expected to double the life expectancy versus no treatment at all and then the second group received only tumor treating field therapy 
BillDoyle_2011P 1 BillDoyle_2011P 513.54 524.78 <NA> what we saw in that trial is that that the life expectancies of both groups so the chemotherapy treated group and the tumor treating field group was the
BillDoyle_2011P 1 BillDoyle_2011P 527.32 533.04 <NA> <unk> the tumor treating field group suffered none of the side effects
BillDoyle_2011P 1 BillDoyle_2011P 532.8 534.93 <NA> typical of
BillDoyle_2011P 1 BillDoyle_2011P 534.69 538.55 <NA> chemotherapy patients they had no pain 
BillDoyle_2011P 1 BillDoyle_2011P 538.27 544.88 <NA> suffered none of the infections <unk> they had no nausea <unk> diarrhea
BillDoyle_2011P 1 BillDoyle_2011P 544.63 549.5 <NA> <unk> constipation fatigue that would be expected 
BillDoyle_2011P 1 BillDoyle_2011P 549.43 554.25 <NA> based on this trial in april of this year the
BillDoyle_2011P 1 BillDoyle_2011P 554.87 561.12 <NA> <unk> approved tumor treating fields for the treatment of patients with recurrent gbm 
BillDoyle_2011P 1 BillDoyle_2011P 561.41 571.56 <NA> importantly it was the first time ever that the fda included in their approval of an oncology treatment a quality of life claim <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 572.9 579.37 <NA> so i 'm going to show you now one of the patients from this trial
BillDoyle_2011P 1 BillDoyle_2011P 581.19 586.09 <NA> robert dill bundi is a famous swiss cycling champion 
BillDoyle_2011P 1 BillDoyle_2011P 585.6 589.75 <NA> he won the gold medal in moscow in the four thousand meter
BillDoyle_2011P 1 BillDoyle_2011P 589.68 591.4 <NA> pursuit <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 590.91 599.75 <NA> and five years ago <unk> robert was diagnosed with gbm <unk> he received the standard treatments he received
BillDoyle_2011P 1 BillDoyle_2011P 601.54 610.97 <NA> <unk> he received high dose radiation to the head and he received first line chemotherapy a year after this treatment in fact this is his
BillDoyle_2011P 1 BillDoyle_2011P 610.74 616.27 <NA> baseline mri <unk> you can see that the black regions in the upper
BillDoyle_2011P 1 BillDoyle_2011P 616.11 619.4 <NA> right quadrant are the areas where he had surgery <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 619.2 621.41 <NA> and a year after that treatment 
BillDoyle_2011P 1 BillDoyle_2011P 621.41 629.97 <NA> his tumor grew back with a vengeance that cloudy white mass that you see is the recurrence
BillDoyle_2011P 1 BillDoyle_2011P 629.96 635.67 <NA> <unk> of the tumor at this point <unk> he was told by his doctors that he had about three months to live <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 635.99 638.4 <NA> he entered our trial <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 637.97 646.75 <NA> and here we can see him getting the therapy first of all these electrodes are noninvasive they 're attached to the
BillDoyle_2011P 1 BillDoyle_2011P 646.54 649.87 <NA> the skin in the area of the tumor here you can see
BillDoyle_2011P 1 BillDoyle_2011P 650.82 656.47 <NA> <unk> technician is placing them on there much like bandages the patients learn to do this themselves
BillDoyle_2011P 1 BillDoyle_2011P 656.22 659.75 <NA> and then the patients can
BillDoyle_2011P 1 BillDoyle_2011P 659.51 669.49 <NA> undergo all the all the activities of their daily life there 's none of the of the tiredness there 's none of what is called the chemo head there 's no sensation 
BillDoyle_2011P 1 BillDoyle_2011P 669.49 671.83 <NA> it doesn 't interfere with
BillDoyle_2011P 1 BillDoyle_2011P 671.64 674.81 <NA> computers or electrical equipment and the
BillDoyle_2011P 1 BillDoyle_2011P 675 684.96 <NA> <unk> therapy is delivered continuously at home without having to go into the hospital either periodically or continually these are
BillDoyle_2011P 1 BillDoyle_2011P 684.96 693.09 <NA> robert 's mris <unk> again <unk> under only ttfield treatment this is a therapy that takes time to work
BillDoyle_2011P 1 BillDoyle_2011P 692.86 699.63 <NA> it 's a medical device it works when it 's on but what we can see is by month six the tumor has
BillDoyle_2011P 1 BillDoyle_2011P 701.57 710.94 <NA> <unk> and it 's begun to melt away it 's still there by month twelve we could argue whether there 's a little bit of
BillDoyle_2011P 1 BillDoyle_2011P 710.81 715.41 <NA> material around the edges <unk> but it 's essentially completely gone it
BillDoyle_2011P 1 BillDoyle_2011P 715.55 724.81 <NA> 's now five years since robert 's diagnosis <unk> and he 's alive <unk> but importantly he 's healthy
BillDoyle_2011P 1 BillDoyle_2011P 724.62 729.97 <NA> and he 's at work <unk> i 'm going to let him in this very short clip describe his
BillDoyle_2011P 1 BillDoyle_2011P 729.93 732.77 <NA> <unk> impressions of the therapy in his own words
BillDoyle_2011P 1 BillDoyle_2011P 763.21 771.59 <NA> <unk> novocure 's also working on lung cancer as the second target <unk> we 've run a phase two trial in switzerland
BillDoyle_2011P 1 BillDoyle_2011P 771.58 779.13 <NA> on again <unk> recurrent patients patients who have received standard therapy and whose cancer has come back
BillDoyle_2011P 1 BillDoyle_2011P 779.99 783.9 <NA> <unk> another clip of a woman named lydia lydia 's a <unk>
BillDoyle_2011P 1 BillDoyle_2011P 784.97 791.25 <NA> <unk> year old farmer in switzerland she was diagnosed with lung cancer five years ago <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 791.25 801.19 <NA> she underwent four different regimes of chemotherapy over two years none of which had an effect her cancer continued to grow 
BillDoyle_2011P 1 BillDoyle_2011P 800.98 804.94 <NA> three years ago <unk> she entered the novocure
BillDoyle_2011P 1 BillDoyle_2011P 804.96 808.25 <NA> <unk> lung cancer trial you can see in her case 
BillDoyle_2011P 1 BillDoyle_2011P 808.04 816.09 <NA> she 's wearing her transducer arrays one of the front of her chest one on the back and then the second pair side to side over the liver 
BillDoyle_2011P 1 BillDoyle_2011P 815.9 827.87 <NA> you can see the tumor treating field field generator but importantly you can also see that she is living her life she is managing her farm <unk> she 's interacting with her kids and her grand kids 
BillDoyle_2011P 1 BillDoyle_2011P 827.87 829.43 <NA> and when we talked
BillDoyle_2011P 1 BillDoyle_2011P 829.83 838.92 <NA> she said that when she was undergoing chemotherapy she had to go to the hospital every month for her infusions her whole family suffered as her side effect profile came and went 
BillDoyle_2011P 1 BillDoyle_2011P 838.92 842.78 <NA> now she can run all of the activities
BillDoyle_2011P 1 BillDoyle_2011P 842.35 846.3 <NA> of her farm <unk> it 's only the beginning
BillDoyle_2011P 1 BillDoyle_2011P 854.93 867.63 <NA> <unk> observed tremendous synergies between chemotherapy and tumor treating fields <unk> there 's research underway now at harvard medical school to pick the optimum pairs to maximize that benefit <unk> 
BillDoyle_2011P 1 BillDoyle_2011P 867.23 879.97 <NA> we also believe that tumor treating fields will work with radiation and interrupt the self repair mechanisms that we have there 's now a new research project underway at the karolinska in sweden to prove that hypothesis
BillDoyle_2011P 1 BillDoyle_2011P 880.1 890.56 <NA> we have more trials planned for lung cancer pancreatic cancer <unk> ovarian cancer and breast cancer and i firmly believe <unk>
BillDoyle_2011P 1 BillDoyle_2011P 890.51 899.36 <NA> that in the next ten years tumor treating fields will be a weapon available to doctors and patients for all of these
BillDoyle_2011P 1 BillDoyle_2011P 904.99 908.55 <NA> <unk> that in the next decades <unk> we will make
BillDoyle_2011P 1 BillDoyle_2011P 908.55 915.12 <NA> big strides on reducing that death rate that has been so challenging in this disease
